Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Non-Viral Transfection Method, Application ...
Transfection is a method used to introduce nucleic acids into mammalian and insect cells. This technique has been used for a wide variety of applications involving protein expression and/or gene ...
PENZBERG, Germany--(BUSINESS WIRE)-- Roche (SWX:RO) (SWX:ROG) (Pink Sheets:RHHBY) announced today the introduction of two new high-performance DNA transfection reagents for its innovative cellular ...
Gene therapy involves the transfer of genetically modified materials into a patient's cells to correct abnormal genes associated with diseases (Sun, 2017). Recent advancements in gene therapy have ...
LONDON--(BUSINESS WIRE)--The transfection reagents and equipment market are poised to grow by USD 319.58 million during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request ...
Response Surface Methods Point the Way to Higher rAAV Yields at Lower Levels of Transfection Reagent
Adverum Biotechnologies describes a multifactor design of experiments methodology that can optimize rAAV vector production while maintaining a specified N/P ratio Researchers at Adverum ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global transfection reagents and equipment market and the market is poised to grow by USD 319.58 million during 2020-2024 at a CAGR of over 6 ...
Transfection alters the genetic makeup of eukaryotic cells by introducing foreign nucleic acids, including DNA, RNA, and small noncoding RNAs such as siRNA, shRNA, and miRNA. Scientists use ...
Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Transfection Reagents & Equipment Market Size & Growth Analysis: According to SNS Insider, the global Transfection Reagents & Equipment Market was valued at ...
Hinnah Campwala (left) is a Principal Scientist in the Cell Biology Development Group at Sartorius BioAnalytical Instruments (Michigan, USA). With a background in drug discovery and immune cell ...
tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...
(MENAFN- GlobeNewsWire - Nasdaq) The non-viral transfection reagents market presents growth opportunities driven by the demand for cost-effective, low-immunogenicity alternatives to viral vectors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback